Nasus Pharma Ltd. Company Profile
NYSE: NSRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Nasus Pharma at a glance
Nasus Pharma Ltd. (NYSE: NSRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Tel Aviv-Yafo, Israel. Nasus Pharma is led by Mr. Brendan P. O'Grady and employs about 7 people. The company's shares have traded publicly since 2025.
At a market capitalization of $42.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002029039, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Nasus Pharma do?
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Nasus Pharma Ltd.
- Ticker
- NYSE: NSRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Brendan P. O'Grady
- Employees
- 7
- Headquarters
- Yigal Alon 65, Tel Aviv-Yafo, Israel
- Phone
- 972 3 573 6632
- Website
- nasuspharma.com
- IPO year
- 2025
- Market cap
- $42.52M
- SEC CIK
- 0002029039
Companies similar to Nasus Pharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRCEGrace Therapeutics Inc. | 2.04 | -2.86% | $42.91M | vs NSRX |
| SCYXSCYNEXIS Inc. | 4.22 | -11.72% | $41.99M | vs NSRX |
| CPHIChina Pharma Holdings Inc. | 0.96 | +12.94% | $41.30M | vs NSRX |
| VERUVeru Inc. | 2.42 | -1.63% | $41.26M | vs NSRX |
| HOWLWerewolf Therapeutics Inc. | 0.91 | -1.10% | $44.23M | vs NSRX |
| IXHLIncannex Healthcare Inc. | 3.20 | +0.63% | $40.14M | vs NSRX |
| FLNAFilana Therapeutics Inc. | 0.8136 | -0.26% | $39.30M | vs NSRX |
| CELUCelularity Inc. Class A | 1.46 | -0.68% | $47.38M | vs NSRX |